Home > Drug Search >
  • company_query: Anergis
  •   > 
Drug Filter
Category:
chemistry (6) biology (48)
Status:
Approved (5) Phase Ⅲ (6) Phase Ⅱ (22) Phase Ⅰ (19) IND Filing (2)
Clinical Stage:
Pending (12) Active (33) Discontinued (4)
Bio-Type:
Gene therapy (1) Vaccine (32) Recombinant cytokines (7) Fusion protein (3)
Indication:
Allergic rhinoconjunctivitis (1) Anemia (2) Bladder cancer (1) Breast cancer (1) Candidiasis (1) Chronic obstructive pulmonary disease (COPD) (2) Avian influenza (1) Rheumatic disorders (1) Gastric cancer (1) HBV infection (3) HCV infection (1) HIV infection (8) Idiopathic pulmonary fibrosis (IPF) (1) Influenza virus infection (1) Somatotropin deficiency (1) Rabies (1) Multiple myeloma (MM) (1) Non-alcoholic fatty liver disease (NAFLD) (1) Non-Hodgkin’s lymphoma (NHL) (2) Ovarian cancer (1) Pancreatic cancer (1) Diphtheria (2) Haemophilus infection (1) Pertussis (2) Prostate cancer (2) Tetanus (2) Varicella zoster virus infections (1) Peanut hypersensitivity (1) Tuberculosis (1) Type 2 diabetes (1) Visceral leishmaniasis (1) Coronavirus infection (1) Cervical intraepithelial neoplasia (1) Hodgkin lymphoma (1) Colorectal cancer (1) Cryopyrin-Associated Periodic Syndromes (CAPS) (1) Diabetes (1) Malaria (1) Neutropenia (5) Infertility (1) Preterm labor (2) West nile virus infection (1) Respiratory syncytial virus infection (1) Mesothelioma (1) Dengue fever (1) Brain cancer (1) Ebola virus disease (EVD) (4) Spinal and bulbar muscular atrophy (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 3 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top